Members |
acceptabilityId |
3-Hydroxybutyrylcarnitine + malonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxybutyrylcarnitine + malonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxydodecanedioate measurement |
Preferred (foundation metadata concept) |
3-Hydroxydodecanedioate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyglutarate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyglutarate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyhexanoylcarnitine + glutarylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyhexanoylcarnitine + glutarylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyrate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyrate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyric aciduria |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyric aciduria (disorder) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxylinoleoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxylinoleoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyoctanoylcarnitine + malonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyoctanoylcarnitine + malonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyoleoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxyoleoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxypalmitoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxypalmitoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxypropionate measurement |
Preferred (foundation metadata concept) |
3-Hydroxypropionate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxysebacate measurement |
Preferred (foundation metadata concept) |
3-Hydroxysebacate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxytetradecadienoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxytetradecadienoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxytetradecenoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxytetradecenoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyvalerate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyvalerate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Ketoacid CoA transferase deficiency |
Acceptable (foundation metadata concept) |
3-Ketoacyl-CoA thiolase deficiency |
Acceptable (foundation metadata concept) |
3-Ketoacyl-CoA triolase deficiency |
Preferred (foundation metadata concept) |
3-Ketoacyl-coenzyme A triolase deficiency |
Acceptable (foundation metadata concept) |
3-Ketoacyl-coenzyme A triolase deficiency (disorder) |
Preferred (foundation metadata concept) |
3-Ketothiolase deficiency |
Acceptable (foundation metadata concept) |
3-Ketothiolase deficiency |
Acceptable (foundation metadata concept) |
3-M syndrome |
Preferred (foundation metadata concept) |
3-Methoxy-4,5- methylenedioxyamphetamine |
Preferred (foundation metadata concept) |
3-Methoxy-4,5- methylenedioxyamphetamine (substance) |
Preferred (foundation metadata concept) |
3-Methoxy-4-hydroxphenylglycol (MHPG) measurement, urine |
Acceptable (foundation metadata concept) |
3-Methoxy-4-hydroxphenylglycol measurement, urine |
Acceptable (foundation metadata concept) |
3-Methoxy-4-hydroxphenylglycol measurement, urine (procedure) |
Preferred (foundation metadata concept) |
3-Methoxy-4-hydroxymandelic acid measurement |
Preferred (foundation metadata concept) |
3-Methoxy-4-hydroxymandelic acid measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methoxy-4-hydroxyphenylglycol measurement, urine |
Acceptable (foundation metadata concept) |
3-Methoxy-o-desmethylencainide measurement |
Preferred (foundation metadata concept) |
3-Methoxy-o-desmethylencainide measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methyl,4-hydroxymandelate measurement |
Preferred (foundation metadata concept) |
3-Methyl,4-hydroxymandelate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methyl-1-pentyn-3-ol |
Preferred (foundation metadata concept) |
3-Methyl-1-pentyn-3-ol (substance) |
Preferred (foundation metadata concept) |
3-Methylcrotonyl glycine |
Preferred (foundation metadata concept) |
3-Methylcrotonyl glycine (substance) |
Preferred (foundation metadata concept) |
3-Methylcrotonyl-CoA carboxylase deficiency |
Acceptable (foundation metadata concept) |
3-Methylcrotonylcarnitine + tiglylcarnitine |
Preferred (foundation metadata concept) |
3-Methylcrotonylcarnitine + tiglylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Methylcrotonylglycine measurement |
Preferred (foundation metadata concept) |
3-Methylcrotonylglycine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methylglutaconate measurement |
Preferred (foundation metadata concept) |
3-Methylglutaconate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 1 |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 1 (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 2 |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 2 (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 3 |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 3 (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 4 |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria type 4 (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria with normal 3-methylglutaconyl-CoA hydratase activity |
Preferred (foundation metadata concept) |
3-Methylglutaconic aciduria with normal 3-methylglutaconyl-coenzyme A hydratase activity |
Acceptable (foundation metadata concept) |
3-Methylglutaconic aciduria with normal 3-methylglutaconyl-coenzyme A hydratase activity (disorder) |
Preferred (foundation metadata concept) |
3-Methylglutaconyl coenzyme A hydratase |
Preferred (foundation metadata concept) |
3-Methylglutaconyl coenzyme A hydratase (substance) |
Preferred (foundation metadata concept) |
3-Methylglutaconyl-CoA hydratase |
Acceptable (foundation metadata concept) |
3-Methylglutaconyl-CoA hydratase deficiency with 3-methylglutaconic acid |
Acceptable (foundation metadata concept) |
3-Methylglutarate measurement |
Preferred (foundation metadata concept) |
3-Methylglutarate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Methylhistidine |
Preferred (foundation metadata concept) |
3-Methylhistidine (substance) |
Preferred (foundation metadata concept) |
3-Methylhydroxybutyric acidaemia |
Acceptable (foundation metadata concept) |
3-Methylhydroxybutyric acidaemia |
Acceptable (foundation metadata concept) |
3-Methylhydroxybutyric acidaemia |
Acceptable (foundation metadata concept) |
3-N-methylspiperone |
Acceptable (foundation metadata concept) |
3-O-methyldopa |
Preferred (foundation metadata concept) |
3-O-methyldopa (substance) |
Preferred (foundation metadata concept) |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
Preferred (foundation metadata concept) |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency (disorder) |
Preferred (foundation metadata concept) |
3-Oxo-5alpha-steroid delta^4^-dehydrogenase |
Preferred (foundation metadata concept) |
3-Oxo-5alpha-steroid delta^4^-dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3-Phosphoglycerate dehydrogenase deficiency |
Preferred (foundation metadata concept) |
3-Phosphoglycerate dehydrogenase deficiency (disorder) |
Preferred (foundation metadata concept) |
3-aci-nitropropanoate oxidase |
Preferred (foundation metadata concept) |